PIMA535940
SARS-CoV-2 Spike Protein S1 Chimeric Recombinant Human Monoclonal Antibody (H6), Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIMA535940-Each-of-1 | In Stock | ₹ 87,175.50 |
PIMA535940 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 87,175.50
GST (18%): ₹ 15,691.59
Total Price: ₹ 1,02,867.09
Antigen
SARS-CoV-2 Spike Protein S1 Chimeric
Classification
Recombinant Monoclonal
Concentration
1 mg/mL
Formulation
PBS with 50% glycerol and 0.03% ProClin 300; pH 7.4
Host Species
Human
Purification Method
Affinity chromatography
Regulatory Status
RUO
Target Species
Virus
Product Type
Antibody
Isotype
IgG1 κ
Applications
ELISA, Lateral Flow
Clone
H6
Conjugate
Unconjugated
Gene Alias
Coronavirus; COVID; Covid 19; COVID19; COVID-19; SARS; SARS Coronavirus; SARS CoV; SARS CoV2; SARS CoV-2; SARS Spike Protein; SARS-CoV2; SARS-CoV-2
Immunogen
Recombinant Human Novel Coronavirus Spike glycoprotein (S) (16-685aa)
Quantity
100 μL
Primary or Secondary
Primary
Content And Storage
-20°C or -80°C if preferred
Form
Liquid
Related Products
Description
- Recombinant anti-SARS-CoV-2 spike is expressed from 293 cells (HEK293)
- It is a chimeric monoclonal antibody combining the mouse variable regions with the constant domains of human IgG1
- SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold symptoms to severe effects including death and respiratory distress
- SARS-CoV-2 Spike Protein is composed of S1 domain and S2 domain (Spike Protein)
- The Spike protein is the main surface antigen of the coronavirus
- The glycosylated Spike protein (as well as the nucleocapsid protein) can be detected in infected cell culture supernatants with antisera from SARS patients
- S1 contains a receptor-binding domain (RBD) that can specifically bind to angiotensin-converting enzyme 2 (ACE2), the receptor on target cells
- CoV diversity is reflected in the variable Spike proteins (S proteins), which have evolved into forms differing in their receptor interactions and their response to various environmental triggers of virus-cell membrane fusion.